Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Mild Cognitive Impairment (MCI), Mild Alzheimer Disease, Memory Deficits
Interventions: home-based self-administered interactive exercise; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment (MCI), Mild Neurocognitive Disorder, Neurocognitive Disorders, Cognitive Dysfunction, Cognition Disorders
Interventions: Accelerated iTBS, Computerized Cognitive Training, Sham Computerized Cognitive Training; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 60 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Gastrointestinal Dysfunction, Physiological Stress, Cognition - Other
Interventions: Yogurt with B. lactis and added honey, Yogurt with heat-inactivated B. lactis and added cane sugar; Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 22 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Mild Alzheimer's Disease, Mild Cognitive Impairment
Interventions: HPP854, Placebo; Drug
Lead sponsor: High Point Pharmaceuticals, LLC.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 3
States / cities: Miami, Florida • Durham, North Carolina • High Point, North Carolina

Conditions: Cognitive Impairment
Interventions: Not listed
Lead sponsor: Synergy Health Solutions; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 2
States / cities: Brooksville, Florida • Centerville, Ohio

Conditions: Parkinson Disease
Interventions: Varenicline, Sugar pill; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 40 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dry Eye, Meibomian Gland Dysfunction
Interventions: Varenicline 0.03Mg/Spray Nasal Soln; Drug
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Blood Pressure, Endothelial Dysfunction
Interventions: Plant based bioequivalent Nitrate supplementation, Placebo; Dietary Supplement
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 40 Years to 75 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Torrance, California

Conditions: Alzheimer's Disease
Interventions: Computer-based Cognitive Training; Procedure
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 60 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Erectile Dysfunction, Metabolic Syndrome, Insulin Resistance
Interventions: Not listed
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Hypercholesterolemia
Interventions: lipoic acid; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 50 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Post Stroke, Post Stroke Hand Rehabilitation
Interventions: Portable Rehabilitation Interface (PoRI); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Milford, Connecticut

Conditions: Erectile Dysfunction
Interventions: Vardenafil ODT, (Staxyn, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 65 Years to 80 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 2
States / cities: Miami, Florida • Knoxville, Tennessee

Conditions: Multiple Sclerosis
Interventions: Prospective Memory Intervention, Educational; Behavioral
Lead sponsor: Trinity Health Of New England; Other
Eligibility: 18 Years to 60 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Stroke Volume Variation, Diastolic Dysfunction
Interventions: Trans thoracic Ultrasound Examination, Intravenous fluid administration; Procedure · Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Endothelial Dysfunction
Interventions: Centella Asiatica, Placebo Comparator; Dietary Supplement
Lead sponsor: National University of Natural Medicine; Other
Eligibility: 50 Years to 85 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Dementia, Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Collaborative Dementia Care Program; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 65 Years and older
Enrollment: 4,005 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 3
States / cities: Indianapolis, Indiana • West Lafayette, Indiana

Conditions: Mild Cognitive Impairment, Caregiver Burnout
Interventions: Telerehabilitation physical activity behavioral (TPAB) intervention; Behavioral
Lead sponsor: Creighton University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Cognitive Impairment, Dementia
Interventions: No interventions; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years to 90 Years
Enrollment: 1,892 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 17
States / cities: Los Angeles, California • Sacramento, California • San Francisco, California + 12 more

Conditions: Brain Concussion, Mild Traumatic Brain Injury, Motor Disorders, Cognitive Impairment
Interventions: tDCS in Youth with mild traumatic brain injury; Device
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 10 Years to 15 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Opioid-Induced Esophageal Dysfunction
Interventions: Opioid cessation, No opioid cessation; Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mild Cognitive Impairment (MCI), Memory Disorders, Age Related, Memory Decline
Interventions: Piano lessons, Music Lessons; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 60 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Breast Cancer, Cognitive Symptoms, Memory Disorders
Interventions: Computer-based Cognitive Training; Device
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Dementia, Cognitive Impairment, Mild, Dementia, Vascular, Dementia, Mixed, Dementia With Lewy Bodies, Dementia Frontal, Dementia Moderate, Dementia of Alzheimer Type, Dementia, Mild
Interventions: Referral for Cognitive Stimulation Therapy, No change to Standard of Care; Behavioral · Other
Lead sponsor: University of Massachusetts, Amherst; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Farmington, Connecticut • New Haven, Connecticut

Search by objective public record fields.

Self-Administered Interactive Exercise Program (Tele-Exergame)

Brain Stimulation and Cognitive Training for MCI

NECTAR Study: Nectar (Honey) Effects on Comfort, Thoughts, and Regularity

Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease

The Role Of Cognitive Impairment In The Use Of The Diskus Inhaler

Varenicline for Gait and Balance Impairment in Parkinson Disease

Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

Effect of Inorganic Nitrate Supplement on Blood Pressure

Computer-Based Training for Mild Alzheimer's Disease

The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction

Antioxidant Functions of Lipoic Acid

PoRI Clinical Trial

Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study

Improving Prospective Memory Via Telehealth

Effect of Diastolic Dysfunction on Dynamic Cardiac Monitors

Centella Asiatica in Older Adults

Indiana University Dementia Screening Trial

Improving Physical Activity With Cognitive Impairment

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury

Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

Music for the Mind Study

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial